Implications of C1q/TNF-related protein-3 (CTRP-3) and progranulin in patients with acute coronary syndrome and stable angina pectoris

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Choi, Kyung M ^a   Hwang, Soon Y ^a   Hong, Ho C ^a   Choi, Hae Y ^a   Yoo, Hye J ^a   Youn, Byung Soo ^b   Baik, Sei H ^a   Seo, Hong S ^c  

^a Korea University College of Medicine   (South Korea)

^b AdipoGen Inc   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

Acute coronary syndrome; Adipokines; C1q tumor necrosis factor related protein 3; Coronary artery disease; Progranulin; Stable angina pectoris

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; C1Q TUMOR NECROSIS FACTOR PROTEIN 3; COMPLEMENT COMPONENT C1Q; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROGRANULIN; SYNAPSIN II; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; GLOMERULUS FILTRATION RATE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PROTEIN BLOOD LEVEL; STABLE ANGINA PECTORIS; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WEIGHT;

ACUTE CORONARY SYNDROME; AGED; ANGINA, STABLE; BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; TUMOR NECROSIS FACTORS;

EID: 84892411374     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-13-14     Document Type: Article

References (39)

1. Matsuzawa Y, Nakamura T, Shimomura I, Kotani K. Visceral fat accumulation and cardiovascular disease. Obes Res 1995, 3(Suppl 5):645S-647S.
2. Bluher M. Clinical relevance of adipokines. Diabetes Metab J 2012, 36(5):317-327. 10.4093/dmj.2012.36.5.317, 3486977, 23130315.
3. Barseghian A, Gawande D, Bajaj M. Adiponectin and vulnerable atherosclerotic plaques. J Am Coll Cardiol 2011, 57(7):761-770. 10.1016/j.jacc.2010.11.011, 21310310.
4. Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA 2004, 101(28):10302-10307. 10.1073/pnas.0403760101, 478567, 15231994.
5. Schaffler A, Buechler C. CTRP family: linking immunity to metabolism. Trends Endocrinol Metab 2012, 23(4):194-204. 10.1016/j.tem.2011.12.003, 22261190.
6. Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord 2013, Epub ahead of print.
7. Hofmann C, Chen N, Obermeier F, Paul G, Buchler C, Kopp A, Falk W, Schaffler A. C1q/TNF-related protein-3 (CTRP-3) is secreted by visceral adipose tissue and exerts antiinflammatory and antifibrotic effects in primary human colonic fibroblasts. Inflamm Bowel Dis 2011, 17(12):2462-2471. 10.1002/ibd.21647, 21351204.
8. Kopp A, Bala M, Buechler C, Falk W, Gross P, Neumeier M, Scholmerich J, Schaffler A. C1q/TNF-related protein-3 represents a novel and endogenous lipopolysaccharide antagonist of the adipose tissue. Endocrinology 2010, 151(11):5267-5278. 10.1210/en.2010-0571, 20739398.
9. Peterson JM, Wei Z, Wong GW. C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. J Biol Chem 2010, 285(51):39691-39701. 10.1074/jbc.M110.180695, 3000950, 20952387.
10. Choi KM, Hwang SY, Hong HC, Yang SJ, Choi HY, Yoo HJ, Lee KW, Nam MS, Park YS, Woo JT, et al. C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome. Diabetes 2012, 61(11):2932-2936. 10.2337/db12-0217, 3478553, 22837306.
11. Yoo HJ, Hwang SY, Hong HC, Choi HY, Yang SJ, Choi DS, Baik SH, Bluher M, Youn BS, Choi KM. Implication of progranulin and C1q/TNF-related protein-3 (CTRP3) on inflammation and atherosclerosis in subjects with or without metabolic syndrome. PLoS One 2013, 8(2):e55744. 10.1371/journal.pone.0055744, 3567086, 23409033.
12. Li JM, Zhang X, Nelson PR, Odgren PR, Nelson JD, Vasiliu C, Park J, Morris M, Lian J, Cutler BS, et al. Temporal evolution of gene expression in rat carotid artery following balloon angioplasty. J Cell Biochem 2007, 101(2):399-410. 10.1002/jcb.21190, 17171642.
13. Maeda T, Wakisaka S. CTRP3/cartducin is induced by transforming growth factor-beta1 and promotes vascular smooth muscle cell proliferation. Cell Biol Int 2010, 34(3):261-266. 10.1042/CBI20090043, 19947921.
14. Yi W, Sun Y, Yuan Y, Lau WB, Zheng Q, Wang X, Wang Y, Shang X, Gao E, Koch WJ, et al. C1q/tumor necrosis factor-related protein-3, a newly identified adipokine, is a novel antiapoptotic, proangiogenic, and cardioprotective molecule in the ischemic mouse heart. Circulation 2012, 125(25):3159-3169. 10.1161/CIRCULATIONAHA.112.099937, 3391311, 22653084.
15. Matsubara T, Mita A, Minami K, Hosooka T, Kitazawa S, Takahashi K, Tamori Y, Yokoi N, Watanabe M, Matsuo E, et al. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab 2012, 15(1):38-50. 10.1016/j.cmet.2011.12.002, 22225875.
16. Youn BS, Bang SI, Kloting N, Park JW, Lee N, Oh JE, Pi KB, Lee TH, Ruschke K, Fasshauer M, et al. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes 2009, 58(3):627-636. 2646061, 19056610.
17. Kojima Y, Ono K, Inoue K, Takagi Y, Kikuta K, Nishimura M, Yoshida Y, Nakashima Y, Matsumae H, Furukawa Y, et al. Progranulin expression in advanced human atherosclerotic plaque. Atherosclerosis 2009, 206(1):102-108. 10.1016/j.atherosclerosis.2009.02.017, 19321167.
18. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, Katus HA, Lindahl B, Morrow DA, et al. Joint ESCAAHAWHFTFftUDoMI Third universal definition of myocardial infarction. Circulation 2012, 126(16):2020-2035. 10.1161/CIR.0b013e31826e1058, 22923432, Joint ESCAAHAWHFTFftUDoMI.
19. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F. Chronic kidney disease epidemiology C: using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145(4):247-254. 10.7326/0003-4819-145-4-200608150-00004, 16908915.
20. Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH. Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans. Clin Endocrinol (Oxf) 2004, 61(1):75-80. 10.1111/j.1365-2265.2004.02063.x, 15212647.
21. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, et al. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002, 106(22):2767-2770. 10.1161/01.CIR.0000042707.50032.19, 12451000.
22. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 1999, 100(25):2473-2476. 10.1161/01.CIR.100.25.2473, 10604883.
23. Costacou T, Zgibor JC, Evans RW, Otvos J, Lopes-Virella MF, Tracy RP, Orchard TJ. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh epidemiology of diabetes complications study. Diabetologia 2005, 48(1):41-48. 10.1007/s00125-004-1597-y, 15616802.
24. Lindsay RS, Resnick HE, Zhu J, Tun ML, Howard BV, Zhang Y, Yeh J, Best LG. Adiponectin and coronary heart disease: the strong heart study. Arterioscler Thromb Vasc Biol 2005, 25(3):e15-e16. 10.1161/01.ATV.0000153090.21990.8c, 15731480.
25. Lawlor DA, Davey Smith G, Ebrahim S, Thompson C, Sattar N. Plasma adiponectin levels are associated with insulin resistance, but do not predict future risk of coronary heart disease in women. J Clin Endocrinol Metab 2005, 90(10):5677-5683. 10.1210/jc.2005-0825, 16076942.
26. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, Danesh J, Whincup PH. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006, 114(7):623-629. 10.1161/CIRCULATIONAHA.106.618918, 16894037.
27. Kim JY, Choi EY, Mun HS, Min PK, Yoon YW, Lee BK, Hong BK, Rim SJ, Kwon HM. Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines. Cardiovasc Diabetol 2013, 12:140. 10.1186/1475-2840-12-140, 3850730, 24088407.
28. Baldasseroni S, Antenore A, Di Serio C, Orso F, Lonetto G, Bartoli N, Foschini A, Marella A, Pratesi A, Scarantino S, et al. Adiponectin, diabetes and ischemic heart failure: a challenging relationship. Cardiovasc Diabetol 2012, 11:151. 10.1186/1475-2840-11-151, 3558365, 23249664.
29. Davis KE, Scherer PE. Adiponectin: no longer the lone soul in the fight against insulin resistance?. Biochem J 2008, 416(2):e7-e9. 10.1042/BJ20082033, 18990088.
30. Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R, Lodish HF. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J 2008, 416(2):161-177. 10.1042/BJ20081240, 18783346.
31. Schmid A, Kopp A, Hanses F, Bala M, Muller M, Schaffler A. The novel adipokine C1q/TNF-related protein-3 is expressed in human adipocytes and regulated by metabolic and infection-related parameters. Exp Clin Endocrinol Diabetes 2012, 120(10):611-617.
32. Weigert J, Neumeier M, Schaffler A, Fleck M, Scholmerich J, Schutz C, Buechler C. The adiponectin paralog CORS-26 has anti-inflammatory properties and is produced by human monocytic cells. FEBS Lett 2005, 579(25):5565-5570. 10.1016/j.febslet.2005.09.022, 16213490.
33. Wolfing B, Buechler C, Weigert J, Neumeier M, Aslanidis C, Schoelmerich J, Schaffler A. Effects of the new C1q/TNF-related protein (CTRP-3) " cartonectin" on the adipocytic secretion of adipokines. Obesity (Silver Spring) 2008, 16(7):1481-1486. 10.1038/oby.2008.206, 18421280.
34. Pradeep AR, Priyanka N, Prasad MV, Kalra N, Kumari M. Association of progranulin and high sensitivity CRP concentrations in gingival crevicular fluid and serum in chronic periodontitis subjects with and without obesity. Dis Markers 2012, 33(4):207-213. 10.1155/2012/173123, 3810772, 22960346.
35. Yilmaz Y, Eren F, Yonal O, Polat Z, Bacha M, Kurt R, Ozturk O, Avsar E. Serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease. Dis Markers 2011, 31(4):205-210. 10.1155/2011/126240, 3826876, 22045426.
36. Qu H, Deng H, Hu Z. Plasma progranulin concentrations are increased in patients with type 2 diabetes and obesity and correlated with insulin resistance. Mediators Inflamm 2013, 2013:360190. 3588183, 23476101.
37. Richter J, Focke D, Ebert T, Kovacs P, Bachmann A, Lossner U, Kralisch S, Kratzsch J, Beige J, Anders M, et al. Serum levels of the adipokine progranulin depend on renal function. Diabetes Care 2013, 36(2):410-414. 10.2337/dc12-0220, 23033238.
38. Tang W, Lu Y, Tian QY, Zhang Y, Guo FJ, Liu GY, Syed NM, Lai Y, Lin EA, Kong L, et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 2011, 332(6028):478-484. 10.1126/science.1199214, 3104397, 21393509.
39. Cenik B, Sephton CF, Kutluk Cenik B, Herz J, Yu G. Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration. J Biol Chem 2012, 287(39):32298-32306. 10.1074/jbc.R112.399170, 3463300, 22859297.